// App-Quantinova.ai

1106 : Mir-223-5p works as an oncomir in vulvar carcinoma by TP63 regulation

Researchers

Presenter

  • Rafael Rocha

Principal Investigators

  • Beatriz De Melo Maia

  • Iara S. Rodrigues

  • Nayra S. Amaral

  • Hui Ling

  • George A. Calin

  • Fernando A. Soares

Medical Centers

  • Federal University of Sao Paulo, Gynecologic Department, Sao Paulo, Brazil

  • A.C. Camargo Cancer Center, Sao Paulo, Brazil

  • 1.MD Anderson Cancer Center, Houston, TX

Locations

  • Brazil

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Vulvar cancer

  • Gynaecological cancer

  • Solid malignancies

Biomarkers

  • Tumor protein p63

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved